5-Bromo-2,3-dimethoxypyridine

Catalog No. :
ACSHGN015
CAS No. :
52605-98-8
Molecular Formula :
C7H8BrNO2
Molecular Weight :
218.05

IUPAC Name:5-bromo-2,3-dimethoxypyridine

5-Bromo-2,3-dimethoxypyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$116.00Login to see priceIn stockInquiry
10g97%$230.00Login to see priceIn stockInquiry
25g97%$573.00Login to see priceIn stockInquiry
100g97%$1948.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2,3-dimethoxypyridine
IUPAC Name5-bromo-2,3-dimethoxypyridine
MDL No.MFCD11052853
Molecular FormulaC7H8BrNO2
Molecular Weight218.05
SMILESCOC1=CC(Br)=CN=C1OC
InChI KeyVSXDRIVAPWWONE-UHFFFAOYSA-N
Synonym5-Bromo-2,3-dimethoxypyridine | 52605-98-8 | MFCD11052853 | Pyridine, 5-bromo-2,3-dimethoxy- | SCHEMBL8916 | 5-Bromo-2,3-dimethoxy-pyridine | DTXSID90502664 | VSXDRIVAPWWONE-UHFFFAOYSA-N | AMY10256 | CCA60598 | AKOS015834226 | DS-16924 | SY258509 | 5-Bromo-2,3-dimethoxypyridine, A
CAS No.52605-98-8
PubChem CID12563084

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACSHGN015 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACEWDO761 route compound structure diagram
    ACEWDO761286947-03-3 In Stock
  4. Then
  5. ACSHGN015 route product structure diagram
    ACSHGN01552605-98-8 In Stock
Inquiry

2. ACSHGN015 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACSHGN015 route product structure diagram
    ACSHGN01552605-98-8 In Stock
Inquiry

Comments (0)